Clinical features and prognosis of patients with COVID‐19 after lung surgery: A retrospective clinical study. Issue 6 (19th February 2021)

• Record Type: Journal Article
• Authors: Bai, Jie; Chu, Hongling; Ma, Shaohua; Ge, Qinggang
• Is Part Of: Asia-Pacific journal of clinical oncology. Volume 17:Issue 6(2021)
• Page Start: 555
• Page End: 560
• Publication Date: 2021-02-19
• Subjects: coronavirus disease 2019 -- immunosuppression -- lung cancer -- lung function -- lung surgery; Oncology -- Pacific Area -- Periodicals; Cancer -- Treatment -- Pacific Area -- Periodicals; Cancer -- Pacific Area -- Periodicals; Cancer -- Treatment -- Periodicals; 616.9940095
• DOI: 10.1111/ajco.13517
• Languages: English
• ISSNs: 1743-7555

Abstract

Abstract: Aim: To evaluate whether the history of lung surgery in patients was associated with poor prognosis of coronavirus disease 2019 (COVID‐19). Methods: Clinical data of patients with COVID‐19 in a single‐center were retrospectively analyzed. Patients with and without lung surgery were matched in 1:4 ratio to compare the differences in clinical characteristics, laboratory results, computed tomography findings, treatment regimens, and prognosis between them. Results: Four patients had a history of lung surgery. The time from surgery to COVID‐19 onset ranged from 3 to 10 days, with a median of 6.75 days. The mortality rate in the surgical group was higher than that in the nonsurgical group (25.0% vs. 6.3%). Conclusion: Patients contracting COVID‐19 after lung surgery presented a higher death rate; hence, it is necessary to omit lung surgery in patients with active COVID‐19 infection.